Клетка "на диете". Научное открытие о влиянии жиров на мышление, физическую активность и обмен веществ - Джозеф Меркола

42. PubMed.gov, https://www.ncbi.nlm.nih.gov/pubmed/?term=migraine+food-i-allergy, accessed November 28, 2016.

43. K. Alpay et al., “Diet Restriction in Migraine, Based on IgG Against Foods: A Clinical Double-blind, Randomised, Cross-over Trial,” Cephalalgia, 30, no. 7 (2010): 829-37, DOblO.l 177/0333102410361404.

44. C. Di Lorenzo et al., “Migraine Improvement During Short Lasting Ketogenesis: A Proof-of-Concept Study,” European Journal of Neurology, 22, no. 1 (2015):170-7, DOI: 10.1111/ene.l2550.

45. C. Di Lorenzo et al., “Diet Transiently Improves Migraine in Two Twin Sisters: Possible Role of Ketogenesis?” Functional Neurology, 28, no. 4 (2013): 305–308.

46. K. L. Munger et al., “Vitamin D Intake and Incidence of Multiple Sclerosis,” Neurology, 62, no. 1, (2004): 60–65, PMID-.14718698.

47. D. Y. Kim et al., “Inflammation-Mediated Memory Dysfunction and Effects of a Ketogenic Diet in a Murine Model of Multiple Sclerosis,” PLoS ONE, 7, no. 5 (2012): e35476, DOI: 10.1371/journal.pone.0035476.

48. M. Storoni and G. T. Plant, “The Therapeutic Potential of the Ketogenic Diet in Treating Progressive Multiple Sclerosis,” Multiple Sclerosis International, 2015 (2015): 681289, DOI: 10.1155/2015/681289.

49. Там же.

50. “Non-Alcoholic Fatty Liver Disease,” American Liver Foundation, http://www.liv-erfoundation.org/abouttheliver/info/nafld/, accessed November 28, 2016.

51. S. S. Sundaram, “Pediatric Non-Alcoholic Fatty Liver Disease,” American Liver Foundation, http://www.liverfoundation.org/chapters/rockymountain/doc-torsnotes/pediatricnafld/, accessed November 28, 2016.

52. J. Ma et al., “Sugar-sweetened Beverage, Diet Soda, and Fatty Liver Disease in the Framingham Heart Study Cohorts,” Journal of Hepatology, 63, no. 2 (2015): 462-69, DOI: 10.1016/j.jhep.2015.03.032.

53. J. D. Browning et al., “Short-term Weight Loss and Hepatic Triglyceride Reduction: Evidence of a Metabolic Advantage with Dietary Carbohydrate Restriction,” The American Journal of Clinical Nutrition, 93, no. 5 (2011): 1048-52. DOI: 10.3945/ajcn.l 10.007674.

54. J. Perez-Guisado and A. Munoz-Serrano, “The Effect of the Spanish Ketogenic Mediterranean Diet on Nonalcoholic Fatty Liver Disease: A Pilot Study,”

Journal of Medicinal Food, 14, no. 7–8 (July-August 2011): 677-80, DOI: 10.1089/ jmf.2011.0075.

55. D. Tendler et al., “The Effect of a Low-Carbohydrate, Ketogenic Diet on Nonalcoholic Fatty Liver Disease: A Pilot Study,” Digestive Diseases and Sciences, 52, no. 2 (February, 2007): 589-93, DOI: 10.1007/sl0620-006-9433-5.

56. P. Kennedy, “The Fat Drug.” The New York Times, March 8, 2014, http://www.ny-times.com/2014/03/09/opinion/Sunday/the-fat-drug.html?_r=0, accessed 12/2/16.

57. H.-Y. Kim et al., “Phosphatidylserine-dependent Neuroprotective Signaling Promoted by Docosahexaenoic Acid,” Prostaglandins, Leukotrienes, and Essential Fatty Acids, 82, no. 4–6 (2010): 165-72, D01:10.1016/j.plefa.2010.02.025.

58. H.-Y. Kim et al., “N-Docosahexaenoylethanolamide Promotes Development of Hippocampal Neurons,” The Biochemical Journal, 435, no. 2 (2011): 327-36, DOI: 10.1042/BJ20102118.

59. R. Palacios-Pelaez, W. J. Lukiw, and N. G. Bazan, “Omega-3 Essential Fatty Acids Modulate Initiation and Progression of Neurodegenerative Disease,” Molecular Neurobiology, 41, no. 2–3 (June 2010): 367-74, DOI: 10.1007/sl2035-010-8139-z.

60. Interview with J. J. Virgin, http://articles.mercola.com/sites/articles/ar-chive/2014/02/09/fish-oil-brain-health.aspx, accessed 12/2/16.

61. S. Smith, “Fish Oil Helped Save Our Son,” CNN, http://www.cnn.com/2012/10/19/ health/fish-oil-brain-injuries/index.html, accessed 12/2/16.

62. M. L. Prins and J. H. Matsumoto, “The Collective Therapeutic Potentialof Cerebral Ketone Metabolism in Traumatic Brain Injury,” Journal of Lipid Research, 55, no. 12 (2014):2450-57, DOI: 10.1194/jlr.R046706.

63. H. Algattas and J. H. Huang, “Traumatic Brain Injury Pathophysiology and Treatments: Early, Intermediate, and Late Phases Post-Injury,” International Journal of Molecular Sciences, 15, no. 1 (2014): 309-41, DOI: 10.3390/ijmsl5010309.

64. Там же.

65. M. L. Prins, L. S. Fujima, and D. A. Hovda, “Age-dependent Reduction of Cortical Contusion Volume by Ketones After Traumatic Brain Injury,” Journal of Neuroscience Research, 82, no. 3 (November 1, 2005): 413-20, DOI: 10.1002/jnr.20633.

66. Z. G. Hu et al., “The Protective Effect of the Ketogenic Diet on Traumatic Brain Injury-Induced Cell Death in Juvenile Rats,” Brain Injury, 23, no. 5 (2009): 459-65, DOI: 10.1080/02699050902788469.

67. “National Diabetes Statistics Report, 2014,” National Center for Chronic Disease Prevention and Health Promotion, http://www.cdc.gov/diabetes/pubs/statsre-portl4/national-diabetes-report-web.pdf, accessed 12/2/16.

68. “Diabetes Facts and Figures,” International Diabetes Foundation, http://www.idf. org/about-diabetes/facts-figures, accessed November 28, 2016.

69. D. Dabelea et al., “Prevalence of Type 1 and Type 2 Diabetes Among Children and Adolescents From 2001 to 2009,” Journal of the American Medical Association, 311, no. 17 (2014): 1778-86, DOI: 10.1001/jama.2014.3201.

70. S. Vijan et al, “Effect of Patients’ Risks and Preferences on Health Gains with Glucose Lowering in Type 2 Diabetes,” JAMA Internal Medicine, 174, no. 8 (2014): 1227-34, DOI: 10.1001/jamainternmed.2014.2894.

71. M. M. Poplawski et al., “Reversal of Diabetic Nephropathy by a Ketogenic Diet,” PLoS ONE, 6, no. 4 (2011): el8604, DOI: 10.1371/journal.pone.0018604.

72. R. D. Feinman et al, “Dietary Carbohydrate Restriction as the First Approach in Diabetes Management: Critical Review and Evidence Base,” Nutrition, 31, no. 1 (2015): 1-13, DOI: 10.1016/j.nut.2014.06.01.1.

73. “Making Healthy Food Choices: Grains and Starchy Vegetables,” American Diabetes Association, http://www.diabetes.org/food-and-fitness/food/what-can-i-eat/ making-healthy-food-choices/grains-and-starchy-vegetables.html, accessed November 28, 2016.

Приложение В

1. M. S. Touillaud et al., “Dietary Lignan Intake and Postmenopausal Breast Cancer Risk by Estrogen and Progesterone Receptor Status,” Journal of the National Cancer Institute, 2007, 99(6):475-86, DOI: 10.1093/jnci/djk096.

2. A. Ahmad et al., “A Review on Therapeutic Potential of Nigella Sativa: A Miracle Herb,” Asian Pacific Journal of Tropical Biomedicine, 2013, 3(5):337–352, DOI:.1016/S2221-1691(13)60075-1.

3. S. Hasani-Ranjbar, Z. Jouyandeh, and M. A. Abdollahi, “A Systematic Review of Anti-Obesity Medicinal Plants – An Update,” Journal of Diabetes and Metabolic Disorders, 2013, 12:28, DOI: 10.1186/2251-6581-12-28.